株式会社グローバルインフォメーション
TEL: 044-952-0102
市場調査レポート

経カテーテル塞栓術・閉塞装置の世界市場:市場規模・シェア・動向分析・予測 (末梢血管疾患・癌・神経科・泌尿器科)

Transcatheter Embolization And Occlusion Devices Market Size, Share & Trends Analysis Report By Type (Coil, Non Coil), By Application (Peripheral Vascular Disease, Oncology, Neurology, Urology), And Segment Forecasts, 2019 - 2026

発行 Grand View Research, Inc. 商品コード 823409
出版日 ページ情報 英文 210 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=111.00円で換算しております。
Back to Top
経カテーテル塞栓術・閉塞装置の世界市場:市場規模・シェア・動向分析・予測 (末梢血管疾患・癌・神経科・泌尿器科) Transcatheter Embolization And Occlusion Devices Market Size, Share & Trends Analysis Report By Type (Coil, Non Coil), By Application (Peripheral Vascular Disease, Oncology, Neurology, Urology), And Segment Forecasts, 2019 - 2026
出版日: 2019年04月11日 ページ情報: 英文 210 Pages
概要

当レポートでは、世界の経腸栄養補給装置市場について調査分析し、市場概要、産業動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

第1章 調査手法・範囲

第2章 エグゼクティブサマリー

第3章 市場の変数、動向、範囲

  • 市場展望
  • 普及率・成長見通しマッピング
  • 産業バリューチェーン分析
  • 市場ダイナミクス
  • 経カテーテル塞栓術・閉塞装置市場の分析ツール

第4章 タイプ別の事業分析

  • 定義・範囲
  • タイプ別の市場シェア分析
  • セグメントのダッシュボード
  • 世界の経カテーテル塞栓術・閉塞装置:タイプ別
  • 市場規模 & 予測および動向分析
  • コイル
  • コイル以外

第5章 用途別の事業分析

  • 定義・範囲
  • 用途別の市場シェア分析
  • セグメントのダッシュボード
  • 世界の経カテーテル塞栓術・閉塞装置:用途別
  • 市場規模 & 予測および動向分析
    • 末梢血管疾患
    • 神経科
    • 泌尿器科

第6章 経カテーテル塞栓術・閉塞装置市場:地域別の市場分析

  • 地域別の市場シェア分析
  • 地域市場のダッシュボード
  • 地域市場のシェア・主要企業
  • SWOT分析:要因別 (政治的 & 法的、経済的および技術的)
  • 市場規模
  • 市場規模 & 予測、数量および動向分析
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第7章 経カテーテル塞栓術・閉塞装置市場:競合市場分析

  • 近年の発展 & 影響分析:主な市場参入企業別
  • 企業/競合の分類
  • ベンダー情勢
    • 主要流通業者・チャネルパートナーのリスト
    • 主要顧客
    • 主要企業の市場シェア分析
    • Boston Scientific Corporation
    • テルモ
    • Medtronic, Inc.
    • DePuy Synthes
    • Stryker Corporation
    • Cordis Corporation
    • St. Jude Medical
    • Pfizer, Inc.
    • Sirtex medical
    • Nordian
図表

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of Abbreviation
  • Table 3 North America transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 4 North America transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 5 North America coils market, by type, 2015 - 2026 (USD Million)
  • Table 6 North America non coils market, by type, 2015 - 2026 (USD Million)
  • Table 7 North America transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 8 North America peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 9 North America oncology market, by type, 2015 - 2026 (USD Million)
  • Table 10 North America neurology market, by type, 2015 - 2026 (USD Million)
  • Table 11 North America urology market, by type, 2015 - 2026 (USD Million)
  • Table 12 North America others market, by type, 2015 - 2026 (USD Million)
  • Table 13 U.S. transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 14 U.S. transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 15 U.S. coils market, by type, 2015 - 2026 (USD Million)
  • Table 16 U.S. non coils market, by type, 2015 - 2026 (USD Million)
  • Table 17 U.S. transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 18 U.S. peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 19 U.S. oncology market, by type, 2015 - 2026 (USD Million)
  • Table 20 U.S. neurology market, by type, 2015 - 2026 (USD Million)
  • Table 21 U.S. urology market, by type, 2015 - 2026 (USD Million)
  • Table 22 U.S. others market, by type, 2015 - 2026 (USD Million)
  • Table 23 Canada transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 24 Canada transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 25 Canada coils market, by type, 2015 - 2026 (USD Million)
  • Table 26 Canada non coils market, by type, 2015 - 2026 (USD Million)
  • Table 27 Canada transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 28 Canada peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 29 Canada oncology market, by type, 2015 - 2026 (USD Million)
  • Table 30 Canada neurology market, by type, 2015 - 2026 (USD Million)
  • Table 31 Canada urology market, by type, 2015 - 2026 (USD Million)
  • Table 32 Canada others market, by type, 2015 - 2026 (USD Million)
  • Table 33 Europe transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 34 Europe transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 35 Europe coils market, by type, 2015 - 2026 (USD Million)
  • Table 36 Europe non coils market, by type, 2015 - 2026 (USD Million)
  • Table 37 Europe transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 38 Europe peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 39 Europe oncology market, by type, 2015 - 2026 (USD Million)
  • Table 40 Europe neurology market, by type, 2015 - 2026 (USD Million)
  • Table 41 Europe urology market, by type, 2015 - 2026 (USD Million)
  • Table 42 Europe others market, by type, 2015 - 2026 (USD Million)
  • Table 43 U.K. transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 44 U.K. transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 45 U.K. coils market, by type, 2015 - 2026 (USD Million)
  • Table 46 U.K. non coils market, by type, 2015 - 2026 (USD Million)
  • Table 47 U.K. transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 48 U.K. peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 49 U.K. oncology market, by type, 2015 - 2026 (USD Million)
  • Table 50 U.K. neurology market, by type, 2015 - 2026 (USD Million)
  • Table 51 U.K. urology market, by type, 2015 - 2026 (USD Million)
  • Table 52 U.K. others market, by type, 2015 - 2026 (USD Million)
  • Table 53 Germany transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 54 Germany transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 55 Germany coils market, by type, 2015 - 2026 (USD Million)
  • Table 56 Germany non coils market, by type, 2015 - 2026 (USD Million)
  • Table 57 Germany transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 58 Germany peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 59 Germany oncology market, by type, 2015 - 2026 (USD Million)
  • Table 60 Germany neurology market, by type, 2015 - 2026 (USD Million)
  • Table 61 Germany urology market, by type, 2015 - 2026 (USD Million)
  • Table 62 Germany others market, by type, 2015 - 2026 (USD Million)
  • Table 63 Italy transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 64 Italy transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 65 Italy coils market, by type, 2015 - 2026 (USD Million)
  • Table 66 Italy non coils market, by type, 2015 - 2026 (USD Million)
  • Table 67 Italy transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 68 Italy peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 69 Italy oncology market, by type, 2015 - 2026 (USD Million)
  • Table 70 Italy neurology market, by type, 2015 - 2026 (USD Million)
  • Table 71 Italy urology market, by type, 2015 - 2026 (USD Million)
  • Table 72 Italy others market, by type, 2015 - 2026 (USD Million)
  • Table 73 France transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 74 France transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 75 France coils market, by type, 2015 - 2026 (USD Million)
  • Table 76 France non coils market, by type, 2015 - 2026 (USD Million)
  • Table 77 France transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 78 France peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 79 France oncology market, by type, 2015 - 2026 (USD Million)
  • Table 80 France neurology market, by type, 2015 - 2026 (USD Million)
  • Table 81 France urology market, by type, 2015 - 2026 (USD Million)
  • Table 82 France others market, by type, 2015 - 2026 (USD Million)
  • Table 83 Spain transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 84 Spain transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 85 Spain coils market, by type, 2015 - 2026 (USD Million)
  • Table 86 Spain non coils market, by type, 2015 - 2026 (USD Million)
  • Table 87 Spain transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 88 Spain peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 89 Spain oncology market, by type, 2015 - 2026 (USD Million)
  • Table 90 Spain neurology market, by type, 2015 - 2026 (USD Million)
  • Table 91 Spain urology market, by type, 2015 - 2026 (USD Million)
  • Table 92 Spain others market, by type, 2015 - 2026 (USD Million)
  • Table 93 Asia Pacific transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 94 Asia Pacific transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 95 Asia Pacific coils market, by type, 2015 - 2026 (USD Million)
  • Table 96 Asia Pacific non coils market, by type, 2015 - 2026 (USD Million)
  • Table 97 Asia Pacific transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 98 Asia Pacific peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 99 Asia Pacific oncology market, by type, 2015 - 2026 (USD Million)
  • Table 100 Asia Pacific neurology market, by type, 2015 - 2026 (USD Million)
  • Table 101 Asia Pacific urology market, by type, 2015 - 2026 (USD Million)
  • Table 102 Asia Pacific others market, by type, 2015 - 2026 (USD Million)
  • Table 103 China transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 104 China transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 105 China coils market, by type, 2015 - 2026 (USD Million)
  • Table 106 China non coils market, by type, 2015 - 2026 (USD Million)
  • Table 107 China transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 108 China peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 109 China oncology market, by type, 2015 - 2026 (USD Million)
  • Table 110 China neurology market, by type, 2015 - 2026 (USD Million)
  • Table 111 China urology market, by type, 2015 - 2026 (USD Million)
  • Table 112 China others market, by type, 2015 - 2026 (USD Million)
  • Table 113 Japan transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 114 Japan transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 115 Japan coils market, by type, 2015 - 2026 (USD Million)
  • Table 116 Japan non coils market, by type, 2015 - 2026 (USD Million)
  • Table 117 Japan transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 118 Japan peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 119 Japan oncology market, by type, 2015 - 2026 (USD Million)
  • Table 120 Japan neurology market, by type, 2015 - 2026 (USD Million)
  • Table 121 Japan urology market, by type, 2015 - 2026 (USD Million)
  • Table 122 Japan others market, by type, 2015 - 2026 (USD Million)
  • Table 123 India transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 124 India transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 125 India coils market, by type, 2015 - 2026 (USD Million)
  • Table 126 India non coils market, by type, 2015 - 2026 (USD Million)
  • Table 127 India transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 128 India peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 129 India oncology market, by type, 2015 - 2026 (USD Million)
  • Table 130 India neurology market, by type, 2015 - 2026 (USD Million)
  • Table 131 India urology market, by type, 2015 - 2026 (USD Million)
  • Table 132 India others market, by type, 2015 - 2026 (USD Million)
  • Table 133 Thailand transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 134 Thailand transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 135 Thailand coils market, by type, 2015 - 2026 (USD Million)
  • Table 136 Thailand non coils market, by type, 2015 - 2026 (USD Million)
  • Table 137 Thailand transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 138 Thailand peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 139 Thailand oncology market, by type, 2015 - 2026 (USD Million)
  • Table 140 Thailand neurology market, by type, 2015 - 2026 (USD Million)
  • Table 141 Thailand urology market, by type, 2015 - 2026 (USD Million)
  • Table 142 Thailand others market, by type, 2015 - 2026 (USD Million)
  • Table 143 South Korea transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 144 South Korea transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 145 South Korea coils market, by type, 2015 - 2026 (USD Million)
  • Table 146 South Korea non coils market, by type, 2015 - 2026 (USD Million)
  • Table 147 South Korea transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 148 South Korea peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 149 South Korea oncology market, by type, 2015 - 2026 (USD Million)
  • Table 150 South Korea neurology market, by type, 2015 - 2026 (USD Million)
  • Table 151 South Korea urology market, by type, 2015 - 2026 (USD Million)
  • Table 152 South Korea others market, by type, 2015 - 2026 (USD Million)
  • Table 153 Latin America transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 154 Latin America transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 155 Latin America coils market, by type, 2015 - 2026 (USD Million)
  • Table 156 Latin America non coils market, by type, 2015 - 2026 (USD Million)
  • Table 157 Latin America transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 158 Latin America peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 159 Latin America oncology market, by type, 2015 - 2026 (USD Million)
  • Table 160 Latin America neurology market, by type, 2015 - 2026 (USD Million)
  • Table 161 Latin America urology market, by type, 2015 - 2026 (USD Million)
  • Table 162 Latin America others market, by type, 2015 - 2026 (USD Million)
  • Table 163 Brazil transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 164 Brazil transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 165 Brazil coils market, by type, 2015 - 2026 (USD Million)
  • Table 166 Brazil non coils market, by type, 2015 - 2026 (USD Million)
  • Table 167 Brazil transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 168 Brazil peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 169 Brazil oncology market, by type, 2015 - 2026 (USD Million)
  • Table 170 Brazil neurology market, by type, 2015 - 2026 (USD Million)
  • Table 171 Brazil urology market, by type, 2015 - 2026 (USD Million)
  • Table 172 Brazil others market, by type, 2015 - 2026 (USD Million)
  • Table 173 Mexico transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 174 Mexico transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 175 Mexico coils market, by type, 2015 - 2026 (USD Million)
  • Table 176 Mexico non coils market, by type, 2015 - 2026 (USD Million)
  • Table 177 Mexico transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 178 Mexico peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 179 Mexico oncology market, by type, 2015 - 2026 (USD Million)
  • Table 180 Mexico neurology market, by type, 2015 - 2026 (USD Million)
  • Table 181 Mexico urology market, by type, 2015 - 2026 (USD Million)
  • Table 182 Mexico others market, by type, 2015 - 2026 (USD Million)
  • Table 183 Columbia transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 184 Columbia transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 185 Columbia coils market, by type, 2015 - 2026 (USD Million)
  • Table 186 Columbia non coils market, by type, 2015 - 2026 (USD Million)
  • Table 187 Columbia transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 188 Columbia peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 189 Columbia oncology market, by type, 2015 - 2026 (USD Million)
  • Table 190 Columbia neurology market, by type, 2015 - 2026 (USD Million)
  • Table 191 Columbia urology market, by type, 2015 - 2026 (USD Million)
  • Table 192 Columbia others market, by type, 2015 - 2026 (USD Million)
  • Table 193 MEA transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 194 MEA transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 195 MEA coils market, by type, 2015 - 2026 (USD Million)
  • Table 196 MEA non coils market, by type, 2015 - 2026 (USD Million)
  • Table 197 MEA transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 198 MEA peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 199 MEA oncology market, by type, 2015 - 2026 (USD Million)
  • Table 200 MEA neurology market, by type, 2015 - 2026 (USD Million)
  • Table 201 MEA urology market, by type, 2015 - 2026 (USD Million)
  • Table 202 MEA others market, by type, 2015 - 2026 (USD Million)
  • Table 203 South Africa transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 204 South Africa transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 205 South Africa coils market, by type, 2015 - 2026 (USD Million)
  • Table 206 South Africa non coils market, by type, 2015 - 2026 (USD Million)
  • Table 207 South Africa transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 208 South Africa peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 209 South Africa oncology market, by type, 2015 - 2026 (USD Million)
  • Table 210 South Africa neurology market, by type, 2015 - 2026 (USD Million)
  • Table 211 South Africa urology market, by type, 2015 - 2026 (USD Million)
  • Table 212 South Africa others market, by type, 2015 - 2026 (USD Million)
  • Table 213 Saudi Arabia transcatheter embolization and occlusion devices market, by countries, 2015 - 2026 (USD Million)
  • Table 214 Saudi Arabia transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 215 Saudi Arabia coils market, by type, 2015 - 2026 (USD Million)
  • Table 216 Saudi Arabia non coils market, by type, 2015 - 2026 (USD Million)
  • Table 217 Saudi Arabia transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 218 Saudi Arabia peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 219 Saudi Arabia oncology market, by type, 2015 - 2026 (USD Million)
  • Table 220 Saudi Arabia neurology market, by type, 2015 - 2026 (USD Million)
  • Table 221 Saudi Arabia urology market, by type, 2015 - 2026 (USD Million)
  • Table 222 Saudi Arabia others market, by type, 20152026 (USD Million)
  • Table 223 UAE transcatheter embolization and occlusion devices market, by product, 2015 - 2026 (USD Million)
  • Table 224 UAE coils market, by type, 2015 - 2026 (USD Million)
  • Table 225 UAE non coils market, by type, 2015 - 2026 (USD Million)
  • Table 226 UAE transcatheter embolization and occlusion devices market, by application, 2015 - 2026 (USD Million)
  • Table 227 UAE peripheral vascular disease market, by type, 2015 - 2026 (USD Million)
  • Table 228 UAE oncology market, by type, 2015 - 2026 (USD Million)
  • Table 229 UAE neurology market, by type, 2015 - 2026 (USD Million)
  • Table 230 UAE urology market, by type, 2015 - 2026 (USD Million)
  • Table 231 UAE others market, by type, 2015 - 2026 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Transcatheter embolization and occlusion devices :Market outlook
  • Fig. 14 Transcatheter embolization and occlusion devices market Competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Transcatheter embolization and occlusion devices market driver impact
  • Fig. 20 Transcatheter embolization and occlusion devices market restraint impact
  • Fig. 21 Transcatheter embolization and occlusion devices strategic initiatives analysis
  • Fig. 22 Transcatheter embolization and occlusion devices market: Type movement analysis
  • Fig. 23 Transcatheter embolization and occlusion devices : Type outlook and key takeaways
  • Fig. 24 Coils market estimates and forecast, 2015 - 2026
  • Fig. 25 Pushable coils market estimates and forecast, 2015 - 2026
  • Fig. 26 Detachable coils market estimates and forecast, 2015 - 2026
  • Fig. 27 Non coils market estimates and forecast, 2015 - 2026
  • Fig. 28 Flow diverting devices market estimates and forecast, 2015 - 2026
  • Fig. 29 Embolization particles market estimates and forecast, 2015 - 2026
  • Fig. 30 Liquid embolics market estimates and forecast, 2015 - 2026
  • Fig. 31 Others market estimates and forecast, 2015 - 2026
  • Fig. 32 Transcatheter embolization and occlusion devices: Application movement analysis
  • Fig. 33 Transcatheter embolization and occlusion devices : Application outlook and key takeaways
  • Fig. 34 Peripheral vascular disease market estimates and forecast, 2015 - 2026
  • Fig. 35 Arterial blockage market estimates and forecast, 2015 - 2026
  • Fig. 36 Venous blood clot market estimates and forecast, 2015 - 2026
  • Fig. 37 Others market estimates and forecast, 2015 - 2026
  • Fig. 38 Oncology market estimates and forecast, 2015 - 2026
  • Fig. 39 Liver cancer market estimates and forecast, 2015 - 2026
  • Fig. 40 Pancreatic cancer market estimates and forecast, 2015 - 2026
  • Fig. 41 Breast cancer market estimates and forecast, 2015 - 2026
  • Fig. 42 Kidney cancer market estimates and forecast, 2015 - 2026
  • Fig. 43 Others market estimates and forecast, 2015 - 2026
  • Fig. 44 Neurology market estimates and forecast, 2015 - 2026
  • Fig. 45 Brain aneurysm market estimates and forecast, 2015 - 2026
  • Fig. 46 Cerebral arteriovenous malformations market estimates and forecast, 2015 - 2026
  • Fig. 47 Others market estimates and forecast, 2015 - 2026
  • Fig. 48 Urology market estimates and forecast, 2015 - 2026
  • Fig. 49 Benign prostatic hyperplasia/Urinary retention market estimates and forecast, 2015 - 2026
  • Fig. 50 Others (varicocele) market estimates and forecast, 2015 - 2026
  • Fig. 51 Transcatheter embolization and occlusion devices: Regional movement analysis
  • Fig. 52 Transcatheter embolization and occlusion devices market: Regional outlook and key takeaways
  • Fig. 53 Global Market Share And Leading Players
  • Fig. 54 North America market share and leading players
  • Fig. 55 Europe market share and leading players
  • Fig. 56 Asia Pacific market share and leading players
  • Fig. 57 Latin America market share and leading players
  • Fig. 58 Middle East & Africa market share and leading players
  • Fig. 59 North America: SWOT Analysis
  • Fig. 60 Europe: SWOT Analysis
  • Fig. 61 Asia Pacific: SWOT Analysis
  • Fig. 62 Latin America: SWOT Analysis
  • Fig. 63 MEA: SWOT Analysis
  • Fig. 64 North America
  • Fig. 65 North America market estimates and forecast, 2015 - 2026
  • Fig. 66 U.S.
  • Fig. 67 U.S. market estimates and forecast, 2015 - 2026
  • Fig. 68 Canada
  • Fig. 69 Canada market estimates and forecast, 2015 - 2026
  • Fig. 70 Europe
  • Fig. 71 Europe market estimates and forecast, 2015 - 2026
  • Fig. 72 Germany
  • Fig. 73 Germany market estimates and forecast, 2015 - 2026
  • Fig. 74 U.K.
  • Fig. 75 U.K. market estimates and forecast, 2015 - 2026
  • Fig. 76 France
  • Fig. 77 France market estimates and forecast, 2015 - 2026
  • Fig. 78 Italy
  • Fig. 79 Italy market estimates and forecast, 2015 - 2026
  • Fig. 80 Spain
  • Fig. 81 Spain market estimates and forecast, 2015 - 2026
  • Fig. 82 Asia Pacific
  • Fig. 83 Asia Pacific market estimates and forecast, 2015 - 2026
  • Fig. 84 China
  • Fig. 85 China market estimates and forecast, 2015 - 2026
  • Fig. 86 Japan
  • Fig. 87 Japan market estimates and forecast, 2015 - 2026
  • Fig. 88 India
  • Fig. 89 India. market estimates and forecast, 2015 - 2026
  • Fig. 90 Thailand
  • Fig. 91 Thailand. market estimates and forecast, 2015 - 2026
  • Fig. 92 South Korea
  • Fig. 93 South Korea market estimates and forecast, 2015 - 2026
  • Fig. 94 Latin America
  • Fig. 95 Latin America market estimates and forecast, 2015 - 2026
  • Fig. 96 Brazil
  • Fig. 97 Brazil market estimates and forecast, 2015 - 2026
  • Fig. 98 Mexico
  • Fig. 99 Mexico market estimates and forecast, 2015 - 2026
  • Fig. 100 Argentina
  • Fig. 101 Argentina market estimates and forecast, 2015 - 2026
  • Fig. 102 Columbia
  • Fig. 103 Columbia market estimates and forecast, 2015 - 2026
  • Fig. 104 Middle East and Africa
  • Fig. 105 MEA market estimates and forecast, 2015 - 2026
  • Fig. 106 South Africa
  • Fig. 107 South Africa market estimates and forecast, 2015 - 2026
  • Fig. 108 Saudi Arabia
  • Fig. 109 Saudi Arabia market estimates and forecast, 2015 - 2026
  • Fig. 110 UAE
  • Fig. 111 UAE market estimates and forecast, 2014 - 2025
  • Fig. 112 Participant categorization- Transcatheter embolization and occlusion devices market
  • Fig. 113 Market share of key market players - Transcatheter embolization and occlusion devices market
目次
Product Code: 978-1-68038-670-7

The global transcatheter embolization and occlusion devices market size is expected to reach USD 6.86 billion by 2026, according to a new study by Grand View Research, Inc. The global market is anticipated to register a strong CAGR of 9.7% from 2019 to 2026. Key drivers of the TEO devices market include increasing adoption of minimally invasive surgeries and rising prevalence of cancer.

In addition, wide usage of embolization technique as a treatment for conditions other than cancer, such as vascular malformations and fibrosis, is fueling the demand for TEO devices globally. Furthermore, introduction of technically advanced products with enhanced efficiency is supporting the global market growth. On the other hand, high cost, stringent regulatory approval procedures, and requirement of experienced healthcare professionals to perform TEO procedures are some of the factors that may have a negative impact on the market development.

Asia Pacific TEO devices market is anticipated to witness highest CAGR from 2019 to 2026 due to increasing healthcare expenditure and improving healthcare infrastructure. Rapid expansion of medical tourism industry in the emerging countries of APAC is also boosting the demand for TEO devices. Brazil was the highest revenue-generating country in Latin America in 2018. Improving healthcare services, growing medical tourism industry, and availability of regulatory framework in the country are further driving the market in Brazil

Further key findings from the study suggest:

Coils accounted for the largest share in 2018. Availability of a broad range of coils in various shapes and sizes enables suitable product selection for different cases, making coiling a preferred treatment for embolization

Moreover, affordability of the commercially available devices spurs demand for coiling in occlusion

Accessories is expected to be the largest type segment due to wide usage of accessories across various modes of embolization and occlusion

North America along with Europe accounted for the largest share in 2018. Presence of advanced healthcare infrastructure, reimbursement coverage, and skilled professionals to perform procedures are some of the factors driving the growth of these regionsm

Moreover, quick adoption of advanced healthcare treatments and products coupled with the presence of well-defined regulatory framework are boosting North America and Europe markets

Key companies in this market include Terumo Corporation; Medtronic, Inc.; Boston Scientific Corporation; Stryker Corporation; Cordis Corporation; DePuy Synthes; St. Jude Medical; Cook Medical; Sirtex Medical Ltd.; and Noridian

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market Segmentation & Scope
    • 1.1.1 Types
    • 1.1.2 Applications
    • 1.1.3 Regional Scope
    • 1.1.4 Estimates and Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 GVR's Internal Database
    • 1.3.3 Secondary Sources
    • 1.3.4 Primary Research
    • 1.3.5 Details of Primary Research
      • 1.3.5.1 Data for primary interviews in North America
      • 1.3.5.2 Data for Primary Interviews in Europe
      • 1.3.5.3 Data for Primary Interviews in Europe
      • 1.3.5.4 Data for Primary Interviews in Latin America
      • 1.3.5.5 Data for Primary Interviews in MEA
  • 1.4 Information or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Model Details
    • 1.6.1 Commodity Flow Analysis (Model 1)
      • 1.6.1.1 Approach 1: Commodity Flow Approach
    • 1.6.2 Volume Price Analysis (Model 2)
      • 1.6.2.1 Approach 2: Volume Price Analysis
  • 1.7 List of Secondary Sources
  • 1.8 List of Primary Sources
  • 1.9 Objectives
    • 1.9.1 Objective 1:
    • 1.9.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Market Outlook
  • 2.2 Segment Outlook
    • 2.2.1 Type Outlook
    • 2.2.2 Application Outlook
    • 2.2.3 Regional Outlook
  • 2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent market outlook
    • 3.1.2 Related/ancillary market outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Industry Value Chain Analysis
    • 3.3.1 Reimbursement framework
  • 3.4 Market Dynamics
    • 3.4.1 Market Driver Analysis
      • 3.4.1.1 Increasing adoption of minimally invasive surgeries
      • 3.4.1.2 Rising prevalence of cancer
    • 3.4.2 Market Restraint Analysis
      • 3.4.2.1 High cost of the products
      • 3.4.2.2 Requirement of skilled professionals
    • 3.4.3 Industry Challenges
  • 3.5 Transcatheter Embolization and Occlusion Devices Market Analysis Tools
    • 3.5.1 Industry Analysis - Porter's
      • 3.5.1.1 Supplier Power
      • 3.5.1.2 Buyer Power
      • 3.5.1.3 Substitution Threat
      • 3.5.1.4 Threat from new entrant
      • 3.5.1.5 Competitive rivalry
    • 3.5.2 PESTEL Analysis
      • 3.5.2.1 Political Landscape
      • 3.5.2.2 Technological Landscape
      • 3.5.2.3 Economic Landscape
    • 3.5.3 Major Deals & Strategic Alliances Analysis
    • 3.5.4 Market Entry Strategies

Chapter 4 Type Business Analysis

  • 4.1 Definitions and Scope
    • 4.1.1 Coils
    • 4.1.2 Non Coil
  • 4.2 Type Market Share Analysis
  • 4.3 Segment Dashboard
  • 4.4 Global Transcatheter Embolization and Occlusion Devices by Type
  • 4.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the following
  • 4.6 Coils
    • 4.6.1 Coils Market Estimates And Forecast, 2015 - 2026
    • 4.6.2 Pushable Coils
      • 4.6.2.1 Pushable Coils Market Estimates And Forecast, 2015 - 2026
    • 4.6.3 Detachable Coils
      • 4.6.3.1 Detachable Coils Market Estimates And Forecast, 2015 - 2026
  • 4.7 Non Coils
    • 4.7.1 Non Coils Market Estimates And Forecast, 2015 - 2026
    • 4.7.2 Flow diverting devices
      • 4.7.2.1 Flow Diverting Devices Market Estimates And Forecast, 2015 - 2026
    • 4.7.3 Embolization particles
      • 4.7.3.1 Embolization Particles Market Estimates And Forecast, 2015 - 2026
    • 4.7.4 Liquid Embolics
      • 4.7.4.1 Liquid Embolics Market Estimates And Forecast, 2015 - 2026
    • 4.7.5 Others
      • 4.7.5.1 Others Market Estimates And Forecast, 2015 - 2026

Chapter 5 Application Business Analysis

  • 5.1 Definitions and Scope
    • 5.1.1 Peripheral Vascular Disease
    • 5.1.2 Oncology
    • 5.1.3 Neurology
    • 5.1.4 Urology
    • 5.1.5 Others
  • 5.2 Application Market Share Analysis
  • 5.3 Segment Dashboard
  • 5.4 Global Transcatheter Embolization and Occlusion Devices by Application
  • 5.5 Market Size & Forecasts and Trend Analysis, 2015 to 2026 for the following
    • 5.5.1 Peripheral Vascular Disease
      • 5.5.1.1 Peripheral Vascular Disease Market Estimates And Forecast, 2015 - 2026
      • 5.5.1.2 Arterial Blockage
      • 5.5.1.2.1 Arterial Blockage Market Estimates And Forecast, 2015 - 2026
      • 5.5.1.3 Venous Blood Clot
      • 5.5.1.3.1 Venous Blood clotMarket Estimates And Forecast, 2015 - 2026
      • 5.5.1.4 Others
      • 5.5.1.4.1 Others Market Estimates And Forecast, 2015 - 2026
    • 5.5.2 Oncology
      • 5.5.2.1 Oncology Market Estimates And Forecast, 2015 - 2026
      • 5.5.2.2 Liver cancer
      • 5.5.2.2.1 Liver cancer Market Estimates And Forecast, 2015 - 2026
      • 5.5.2.3 Pancreatic cancer
      • 5.5.2.3.1 Pancreatic cancer Market Estimates And Forecast, 2015 - 2026
      • 5.5.2.4 Breast cancer
      • 5.5.2.4.1 Breast cancer Market Estimates And Forecast, 2015 - 2026
      • 5.5.2.5 Kidney cancer
      • 5.5.2.5.1 Kidney cancer Market Estimates And Forecast, 2015 - 2026
      • 5.5.2.6 Others
      • 5.5.2.6.1 Others Market Estimates And Forecast, 2015 - 2026
    • 5.5.3 Neurology
      • 5.5.3.1 Neurology Market Estimates And Forecast, 2015 - 2026
      • 5.5.3.2 Brain Aneurysm
      • 5.5.3.2.1 Brain Aneurysm Market Estimates And Forecast, 2015 - 2026
      • 5.5.3.3 Cerebral arteriovenous malformations
      • 5.5.3.3.1 Cerebral arteriovenous malformations Market Estimates And Forecast, 2015 - 2026
      • 5.5.3.4 Others
      • 5.5.3.4.1 Others Market Estimates And Forecast, 2015 - 2026
    • 5.5.4 Urology
      • 5.5.4.1 Urology Market Estimates And Forecast, 2015 - 2026
      • 5.5.4.2 Benign prostatic hyperplasia/Urinary retention
      • 5.5.4.2.1 Benign prostatic hyperplasia/Urinary retention Market Estimates And Forecast, 2015 - 2026
      • 5.5.4.3 Others (varicocele)
      • 5.5.4.3.1 Others (varicocele) Market Estimates And Forecast, 2015 - 2026

Chapter 6 Transcatheter Embolization and Occlusion Devices Market: Regional Market Analysis, 2015 - 2026 (Value & Volume) (USD Million)

  • 6.1 Regional market share analysis, 2018 & 2026
  • 6.2 Regional Market Dashboard
  • 6.3 Global Regional Market Snapshot
  • 6.4 Regional Market Share and Leading Players, 2018
    • 6.4.1 North America
    • 6.4.2 Europe
    • 6.4.3 Asia Pacific
    • 6.4.4 Latin America
    • 6.4.5 Middle East & Africa
  • 6.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 6.5.1 North America: SWOT Analysis
    • 6.5.2 Europe: SWOT Analysis
    • 6.5.3 Asia Pacific: SWOT Analysis
    • 6.5.4 Latin America: SWOT Analysis
    • 6.5.5 Middle East & Africa: SWOT Analysis
  • 6.6 Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2026:
  • 6.7 North America
    • 6.7.1 Market estimates and forecast, 2015 - 2026 (Value & Volume)
    • 6.7.2 U.S.
      • 6.7.2.1 U.S. market estimates and forecast, 2015 - 2026
    • 6.7.3 Canada
      • 6.7.3.1 Canada market estimates and forecast, 2015 - 2026
  • 6.8 Europe
    • 6.8.1 Europe market estimates and forecast, 2015 - 2026
    • 6.8.2 Germany
      • 6.8.2.1 Germany market estimates and forecast, 2015 - 2026
    • 6.8.3 U.K.
      • 6.8.3.1 U.K. market estimates and forecast, 2015 - 2026
    • 6.8.4 France
      • 6.8.4.1 France market estimates and forecast, 2015 - 2026
    • 6.8.5 Italy
      • 6.8.5.1 Italy market estimates and forecast, 2015 - 2026
    • 6.8.6 Spain
      • 6.8.6.1 Spain market estimates and forecast, 2015 - 2026
  • 6.9 Asia Pacific
    • 6.9.1 Asia Pacific market estimates and forecast, 2015 - 2026
    • 6.9.2 China
      • 6.9.2.1 Market estimates and forecast, 2015 - 2026 (Value & Volume)
    • 6.9.3 Japan
      • 6.9.3.1 Japan market estimates and forecast, 2015 - 2026
    • 6.9.4 India
      • 6.9.4.1 India market estimates and forecast, 2015 - 2026
    • 6.9.5 Thailand
      • 6.9.5.1 Market estimates and forecast, 2015 - 2026 (Value & Volume)
    • 6.9.6 South Korea
      • 6.9.6.1 South Korea market estimates and forecast, 2015 - 2026
  • 6.10 Latin America
    • 6.10.1 Latin America market estimates and forecast, 2015 - 2026
    • 6.10.2 Brazil
      • 6.10.2.1 Brazil market estimates and forecast, 2015 - 2026
    • 6.10.3 Mexico
      • 6.10.3.1 Market estimates and forecast, 2015 - 2026 (Value & Volume)
    • 6.10.4 Argentina
      • 6.10.4.1 Argentina market estimates and forecast, 2015 - 2026
    • 6.10.5 Columbia
      • 6.10.5.1 Columbia market estimates and forecast, 2015 - 2026
  • 6.11 Middle East and Africa
    • 6.11.1 MEA Market estimates and forecast, 2015 - 2026 (Value & Volume)
    • 6.11.2 South Africa
      • 6.11.2.1 South Africa market estimates and forecast, 2015 - 2026
    • 6.11.3 Saudi Arabia
      • 6.11.3.1 Saudi Arabia market estimates and forecast, 2015 - 2026
    • 6.11.4 UAE
      • 6.11.4.1 UAE market estimates and forecast, 2014 - 2025

Chapter 7 Transcatheter Embolization and Occlusion Devices Market: Competitive Market Analysis,

  • 7.1 Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2 Company/Competition Categorization
    • 7.2.1 Innovators
  • 7.3 Vendor Landscape
    • 7.3.1 List of Key Distributors and Channel Partners
    • 7.3.2 Key customers
    • 7.3.3 Key company market share analysis, 2018
    • 7.3.4 Boston Scientific Corporation
      • 7.3.4.1 Company overview
      • 7.3.4.2 Financial performance
      • 7.3.4.3 Product benchmarking
      • 7.3.4.4 Strategic initiatives
    • 7.3.5 Terumo Corporation
      • 7.3.5.1 Company overview
      • 7.3.5.2 Financial performance
      • 7.3.5.3 Product benchmarking
      • 7.3.5.4 Strategic initiatives
    • 7.3.6 Medtronic, Inc.
      • 7.3.6.1 Company overview
      • 7.3.6.2 Financial performance
      • 7.3.6.3 Product benchmarking
      • 7.3.6.4 Strategic initiatives
    • 7.3.7 DePuy Synthes
      • 7.3.7.1 Company overview
      • 7.3.7.2 Financial performance
      • 7.3.7.3 Product benchmarking
      • 7.3.7.4 Strategic initiatives
    • 7.3.8 Stryker Corporation
      • 7.3.8.1 Company overview
      • 7.3.8.2 Financial performance
      • 7.3.8.3 Product benchmarking
      • 7.3.8.4 Strategic initiatives
    • 7.3.9 Cordis Corporation
      • 7.3.9.1 Company overview
      • 7.3.9.2 Financial performance
      • 7.3.9.3 Product benchmarking
      • 7.3.9.4 Strategic initiatives
    • 7.3.10 St. Jude Medical
      • 7.3.10.1 Company overview
      • 7.3.10.2 Financial performance
      • 7.3.10.3 Product benchmarking
      • 7.3.10.4 Strategic initiatives
    • 7.3.11 Pfizer, Inc.
      • 7.3.11.1 Company overview
      • 7.3.11.2 Financial performance
      • 7.3.11.3 Product benchmarking
      • 7.3.11.4 Strategic initiatives
    • 7.3.12 Sirtex medical
      • 7.3.12.1 Company overview
      • 7.3.12.2 Financial performance
      • 7.3.12.3 Product benchmarking
      • 7.3.12.4 Strategic initiatives
    • 7.3.13 Nordian
      • 7.3.13.1 Company overview
      • 7.3.13.2 Financial performance
      • 7.3.13.3 Product benchmarking
      • 7.3.13.4 Strategic initiatives
Back to Top